Mechanistic Exploration of Therapeutic Targets and Treatable Traits to Improve CNS Outcomes in People with HIV

US · IL National Institutes of Health (NIH) grant unknown #FOR-MH-26-165

Summary

This NIH funding opportunity (FOR-MH-26-165) seeks to support mechanistic research exploring therapeutic targets and treatable traits aimed at improving central nervous system (CNS) outcomes in people living with HIV. The opportunity is issued by the National Institutes of Health under the Department of Health and Human Services. It is currently in a forecasted status, indicating it has been announced in advance of a formal solicitation. The focus is on biomedical/clinical research addressing HIV-associated CNS complications.

What they want

Fund mechanistic research to: (1) identify and characterize therapeutic targets relevant to CNS outcomes in HIV-positive individuals; (2) explore treatable traits that may be modified to improve neurological and cognitive outcomes; and (3) advance understanding of CNS pathophysiology in the context of HIV infection. Specific research mechanisms, award structures, and detailed requirements are expected to be published in the formal solicitation.

Risks & flags

Opportunity is in 'forecasted' status only — full solicitation details, eligibility, and requirements are not yet published; no actionable submission data available.
No dollar values, period of performance, or evaluation criteria disclosed at this stage — insufficient information to assess competitive landscape.

Market context

inferred from NAICS

Professional, Scientific & Technical Services

NAICS 541714

US market size: $2.0T
Typical award: $25K – $50M

Typical buyers

All federal civilianDoDStates

Commonly required

8(a)WOSBSDVOSBPE/PMP

Sector-level estimate — full code lookup not yet in catalog.

Mechanistic Exploration of Therapeutic Tar…

$unknown

Onboard ↗